Bremer C, Ntziachristos V, Weitkamp B, Theilmeier G, Heindel W, Weissleder R. (2005) Optical imaging of spontaneous breast tumors using protease sensing 'smart' optical probes. Invest Radiol. 2005 Jun;40(6):321-7.
Persigehl T, Heindel W, Bremer C. (2005) MR and optical approaches to molecular imaging. Abdom Imaging 2005; 30:342-354.
Matuszewski L, Persigehl T, Wall A, Schwindt W, Tombach B, Fobker M, Poremba C, Ebert W, Heindel W, Bremer C. (2005) Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency. Radiology 2005; 235:155-161.
Kessler T, Bieker R, Padro T, Schwoppe C, Persigehl T, Bremer C, Kreuter M, Berdel WE, Mesters RM. (2005) Inhibition of tumor growth by RGD peptide-directed delivery of truncated tissue factor to the tumor vasculature. Clin Cancer Res 2005; 11:6317-6324.
Kopka K, Law MP, Breyholz HJ, Faust A, Höltke C, Riemann B, Schober O, Schäfers M, Wagner S. (2005) Non-invasive molecular imaging of beta-adrenoceptors in vivo: perspectives for PET-radioligands. Curr Med Chem. 2005;12(18):2057-74. Review.
Breyholz HJ, Schäfers M, Wagner S, Höltke C, Faust A, Rabeneck H, Levkau B, Schober O, Kopka K. (2005) C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging. J Med Chem. 2005 May 5;48(9):3400-9.
Wagner S, Law M, Riemann B, Pike VW, Breyholz HJ, Höltke C, Faust A, Schober O, Schäfers M, Kopka K. (2005) Synthesis of (R)- and (S)-[O-methyl-11C]N-[2-[3-(2-cyano-phenoxy)-2-hydroxy-propylamino]-ethyl]-N0-(4-methoxy-phenyl)-urea as candidate high affinity b1-adrenoceptor PET radioligands. J Label Compd Radiopharm 2005; 48: 721–733.